Precision Medicine Readiness Report 2020 NSCLC: An Axis for Change
22 Mar 2023
The second Report in our Axis for Change series analyzes the broken diagnostic testing ecosystem impeding the delivery of precision medicines today and recommends a collaborative industry solution
The Problem
A lack of collaboration between precision medicine stakeholders has led to a broken testing ecosystem with only 50% of eligible patients in oncology getting access to the right treatment
The Solution
Diaceutics’ Network solution has been purpose built to solve the broken testing ecosystem by enabling the industry-wide collaboration needed to get every patient the treatment they deserve
In the Report you'll gain insights into
- Facilitating CDx partnerships and collaborations in real time enabling treatments to get to market faster
- Removing local and regional restrictions to test adoption through access to a global network of implementation partners
- Providing in-lab education, external quality assessment (EQA) support, and training to prepare labs for biomarker tests coming to market
- Managing Dx quality and inter-lab variability, increasing the cumulative number of patients testing positive
- Unlocking access to the world’s largest repository of diagnostic testing data from 2500+ labs in 51 countries to inform better treatment decisions